STALEVO (carbidopa, levodopa, and entacapone) tablet, film coated [Novartis Pharmaceuticals Corporation]
Updated Date: Tue, 14 Jan 2020 00:00:00 EST Source link...
Tag : Novartis
STAT Plus: As families in Europe clamor for its pricey gene therapy, Novartis creates a lottery
Seeking to provide its pricey gene therapy to patients in countries where the drug is not yet approved, Novartis (NVS) has taken the unusual step...
Novartis eyes give-away of costly therapy for babies
Swiss pharmaceutical company Novartis is preparing to give away 100 doses of the world’s most expensive drug, which treats a rare childhood disorder, but its...
STAT Plus: Pharmalittle: Novartis plans a lottery for the world’s priciest drug; Trump importation could hit Gilead
Rise and shine, everyone, another busy day is on the way. The holiday season may be fast approaching but there is still work to be...
STAT Plus: Pharmalittle: Novartis to pay $9.7 billion for The Medicines Co.; Trump bashes Pelosi drug pricing bill
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-familiar routine of meetings, Skype...
Global Ophthalmology Therapeutics Market 2019-2023 | Evolving Opportunities with ALLERGAN and Novartis AG | Technavio
LONDON–(BUSINESS WIRE)– #HealthcareDevices–Global ophthalmology therapeutics market is poised to grow by USD 9.6 billion during 2019-2023 at a CAGR of nearly 6% during the forecast...
With $9.7 billion acquisition, Novartis bets that heart drugs are coming back
Novartis’ $9.7 billion acquisition of The Medicines Company, which the companies announced Sunday after days of rumors, is a story of second acts. It represents...
The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion
PARSIPPANY, N.J.–(BUSINESS WIRE)—- $MDCO–The Medicines Company (NASDAQ: MDCO) announced today that it has entered into definitive agreement in which Novartis AG will acquire The Medicines...
Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the...
STAT Plus: Pharmalittle: Pelosi claims trade deal shows progress on drug issues; Novartis suffers another trial setback
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal...
STAT Plus: Pharmalittle: FDA places hold on Novartis trial for gene therapy; FDA floats plan for combating shortages
Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? While you ponder the...
Novartis gene therapy brings in $160 million, beating expectations
Zolgensma, a lifesaving treatment for infants and the world’s most expensive drug, has been used to treat 100 patients since its launch and brought in...
STAT Plus: Novartis partners with Microsoft to use AI in drug development
Novartis and Microsoft have inked a five-year deal to use artificial intelligence to design molecules, personalize medication dosing, and optimize the manufacturing of CAR-T cancer...
Digital Dose Inhalers Market 2019-2023 – Evolving Opportunities With AstraZeneca Plc and Novartis AG | Technavio
LONDON–(BUSINESS WIRE)– #Biotechnology–The global digital dose inhalers market size will grow by USD 989.44 million during 2019-2023. Source link...
Novartis stops distribution of Zantac
Zantac manufacturer Novartis has stopped the distribution of its heartburn medication across all available markets, including the United States and Canada, Reuters reported.The halt in...
Sanofi’s billion-dollar multiple sclerosis drug faces competitive threat from Novartis, J&J agents
On Friday, Novartis presented data at ECTRIMS showing that Arzerra had superior efficacy to Sanofi’s Aubagio. Johnson & Johnson’s Janssen division had presented data for...
STAT Plus: Reeling from scandal, Novartis vows to voluntarily release info on manipulated data in the future
Seeking to appease angry regulators, Novartis (NVS) committed to notifying the Food and Drug Administration within five business days of learning of any “credible allegation”...
STAT Plus: Pharmalittle: AstraZeneca stumbles in lung cancer; FDA official on Novartis data scandal says ‘we got lucky’
Rise and shine, everyone, the middle of the week is already here. Time flies when you’re having … fill in the blank here. Meanwhile, a...
Top scientist categorically denies any wrongdoing in Novartis data manipulation scandal
The Novartis scientist who was ousted by the drug maker in connection with a scandal over data manipulation broke his silence late Monday, saying through...
STAT Plus: Pharmalittle: Novartis exec sold stock before FDA announced data scandal; FDA OKs fewer new generics this year
Good morning, everyone, and welcome to another working week. We hope the weekend respite — or holiday break, for some — was invigorating and refreshing,...